DV
Dividend Vision

TWST — Twist Bioscience Corp.

Twist Bioscience Corp. (TWST)

Total return is 746.9% over the past 7.8 years, 524.4 points ahead of SPY at 222.5%. Its deepest 1-year drawdown was 25.5%.

TWST is an equity fund that holds Twist Bioscience Corp., a synthetic biology company focused on DNA-based technologies and services. The fund does not currently pay distributions and carries no listed expense ratio, as it appears to be a single-stock position rather than a diversified ETF product. This structure appeals primarily to investors seeking direct exposure to a specific biotech company rather than those prioritizing dividend income.

TWST key facts

Asset type
Stock
Asset class
Equity
Inception date
10/31/2018
Distribution frequency
None
Last close
$118.57
Market cap
$7,435,219,456
Average volume
1140835.0
Beta
2.158
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.23